Cargando…
Association between IL-1 Gene Polymorphisms and Stage III Grade B Periodontitis in Polish Population
Periodontitis is a chronic multifactorial inflammatory disease originating from microbial, environmental and genetic factors. The present study aimed to find an association of genetic polymorphisms at IL-1A(−889) and IL-1B(+3953) loci in Polish patients with stage III grade B periodontitis and perio...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690736/ https://www.ncbi.nlm.nih.gov/pubmed/36429405 http://dx.doi.org/10.3390/ijerph192214687 |
Sumario: | Periodontitis is a chronic multifactorial inflammatory disease originating from microbial, environmental and genetic factors. The present study aimed to find an association of genetic polymorphisms at IL-1A(−889) and IL-1B(+3953) loci in Polish patients with stage III grade B periodontitis and periodontally healthy subjects. Fifty patients with stage III grade B periodontitis (tests) and thirty-five periodontally healthy controls were included in the study. To determine IL-1A and IL-1B gene polymorphisms, buccal swab-derived DNA obtained by means of the GenoType PST test was used. There were no statistically significant differences regarding the prevalence of IL-1A(−889) or IL-1B(+3953) alleles between groups. The frequencies of different IL-1A(−889) genotypes did not differ significantly between groups. The IL-1B(+3953) C/T genotype was significantly more predominant in periodontitis patients than in controls, whereas C/C genotype prevalence was significantly lower in the test group. Complex genotypes consisting of at least one IL-1A(−889) and IL-1B(+3953) T allele occurred significantly more frequently in subjects with periodontitis. Stage III grade B periodontitis may be associated with the IL-1B(+3953) T allele and composite IL-1 polymorphism. Reduced susceptibility to periodontal disease was present in IL-1A(−889) and IL-1B(+3953) C/C homozygotic patients. |
---|